BioXcel Therapeutics, Inc.
BTAIQ- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720893
No open-market purchases or sales by BioXcel Therapeutics, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $8.69M in total; Oaktree Capital is the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in BioXcel Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- 0 vs. Q4 2025
- Shares held
- 5.44M
- +2.20M (+67.7%) vs. Q4 2025
- Total value
- $7.28M
- +$2.08M (+40.0%) vs. Q4 2025
- New holders
- 8
- 9 more added
- Sold out
- 8
- 7 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BTAIQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $8.69M |
| Q1 2026 | 40 | $7.28M |
| Q4 2025 | 41 | $5.66M |
| Q3 2025 | 35 | $6.05M |
| Q2 2025 | 35 | $1.09M |
| Q1 2025 | 31 | $769.7K |
| Q4 2024 | 49 | $3.22M |
| Q3 2024 | 50 | $1.89M |
| Q2 2024 | 74 | $12.5M |
| Q1 2024 | 74 | $26.1M |
| Q4 2023 | 73 | $27.6M |
| Q3 2023 | 86 | $25.8M |
| Q2 2023 | 88 | $117.8M |
| Q1 2023 | 97 | $325.0M |
| Q4 2022 | 84 | $288.9M |
| Q3 2022 | 85 | $140.3M |
| Q2 2022 | 94 | $167.4M |
| Q1 2022 | 96 | $273.9M |
| Q4 2021 | 93 | $283.1M |
| Q3 2021 | 104 | $388.3M |
| Q2 2021 | 109 | $378.6M |
| Q1 2021 | 118 | $475.2M |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding BioXcel Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Millennium Management LLC | 1,936,760 | $2.60M | 0.00% | +101,568+5.5% | Added |
| Armistice Capital, LLC | 1,910,076 | $2.56M | 0.08% | +1,910,076 | New |
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 241,188 | $323.2K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 230,168 | $308.7K | 0.00% | +24,000+11.6% | Added |
| Vanguard Capital Management LLC | 207,339 | $277.8K | 0.00% | +207,339 | New |
| Jones Financial Companies LLLP | 131,789 | $166.1K | 0.00% | −5,901−4.3% | Reduced |
| Man Group plc | 96,473 | $129.3K | 0.00% | +39,648+69.8% | Added |
| State Street Corp | 92,118 | $123.4K | 0.00% | +28,900+45.7% | Added |
| FMR LLC | 90,300 | $121.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 84,921 | $113.8K | 0.00% | +84,921 | New |
| BlackRock, Inc. | 84,282 | $112.9K | 0.00% | −114−0.1% | Reduced |
| Wiley Bros.-Aintree Capital, LLC | 80,864 | $108.4K | 0.00% | +80,864 | New |
| UBS Group AG | 52,788 | $70.7K | 0.00% | +14,448+37.7% | Added |
| Oaktree Fund Advisors, LLC | 42,913 | $57.5K | 0.10% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 41,000 | $54.9K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 36,313 | $48.7K | 0.00% | −2,057−5.4% | Reduced |
| Beacon Pointe Advisors, LLC | 18,877 | $25.3K | 0.00% | +18,877 | New |
| Advisor Group Holdings, Inc. | 16,214 | $21.7K | 0.00% | +465+3.0% | Added |
| Portfolio Strategies, Inc. | 12,178 | $16.3K | 0.00% | 00.0% | Unchanged |
| Diversify Wealth Management, LLC | 15,000 | $15.6K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 10,588 | $14.2K | 0.00% | +9,124+623.2% | Added |
| Wells Fargo & Company | 4,319 | $5.79K | 0.00% | −6−0.1% | Reduced |
| Tower Research Capital LLC (TRC) | 1,718 | $2.30K | 0.00% | +1,718 | New |
| GWM Advisors LLC | 1,331 | $1.78K | 0.00% | 00.0% | Unchanged |
| Vanguard Global Advisers, LLC | 493 | $661 | 0.00% | +493 | New |
| Silver Grove Financial Group, Inc. | 334 | $447 | 0.00% | +334 | New |
| Washington Trust Advisors, Inc. | 160 | $214 | 0.00% | 00.0% | Unchanged |
| Annis Gardner Whiting Capital Advisors, LLC | 156 | $210 | 0.00% | +44+39.3% | Added |
| Parkside Financial Bank & Trust | 112 | $151 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 60 | $80 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 59 | $79 | 0.00% | +47+391.7% | Added |
| JPMorgan Chase & Co | 45 | $54 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 25 | $31 | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 21 | $28 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 14 | $19 | 0.00% | −155−91.7% | Reduced |
| IFP Advisors, Inc | 13 | $17 | 0.00% | −4,357−99.7% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2 | $3 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1 | $1 | 0.00% | −3,184−100.0% | Reduced |
| US Bancorp | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Triumph Capital Management | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −127,501−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −120,102−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,062−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −17,068−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −12,303−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −12,079−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1,642−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −1,446−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |